APRE
Aprea Therapeutics·NASDAQ
--
--(--)
--
--(--)
APRE Filings
Filing Date
Form Description
Form Type
2026-02-02
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-02-02 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-02-02
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-02-02 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-29
Form 8-K - Current report
Key Events
2026-01-29 · Key Events
Form 8-K - Current report
2026-01-28
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-28 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-23
Form 8-K - Current report
Key Events
2026-01-23 · Key Events
Form 8-K - Current report
2026-01-09
Form 8-K - Current report
Key Events
2026-01-09 · Key Events
Form 8-K - Current report
2025-12-30
Form EFFECT - Notice of Effectiveness
2025-12-30 ·
Form EFFECT - Notice of Effectiveness
2025-12-30
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-30 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-29
Form D - Notice of Exempt Offering of Securities
2025-12-29 ·
Form D - Notice of Exempt Offering of Securities
2025-12-19
Form S-3 - Registration statement under Securities Act of 1933
2025-12-19 ·
Form S-3 - Registration statement under Securities Act of 1933
